RUNBEN BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 603193 for the last quarter is 164.19 M CNY, and it's 20.92% lower compared to the previous quarter. The net income of Q1 24 is 35.47 M CNY.